Last reviewed · How we verify

NCT06833294

GentleFit Non-Invasive Ventilation (NIV) Interface Trial

Terminated Last updated 9 February 2026
What this trial tests

trial testing GentleFit Mask, GentleFit Prong, Standard of Care Interface in Device Ineffective in 4 participants. Terminated before completion.

Timeline
24 October 2025
Primary endpoint
20 January 2026
20 January 2026

Quick facts

Lead sponsorChildren's Hospital of Philadelphia
StatusTerminated
Study typeOBSERVATIONAL
Enrollment4
Start date24 October 2025
Primary completion20 January 2026
Estimated completion20 January 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Children's Hospital of Philadelphia

Who can join

Adults 38 Weeks to 3, any sex, with Device Ineffective or Device Induced Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective is to compare pressure achieved by GentleFit Non-Invasive Ventilation (NIV) nasal mask and nasal prong to standard of care interface. Secondary objectives include to monitor skin integrity, clinical parameters, and adverse events. Additionally, to evaluate clinician opinion of ease of application and overall fit of GentleFit NIV interfaces and headgear.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Children's Hospital of Philadelphia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06833294.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing